idarubicin hydrochloride

Idarubicin An orally administered anthracycline antineoplastic. The compound has shown activity against breast cancer, lymphomas and leukemias, together with the potential for reduced cardiac toxicity.

Molecular Formula: C₂₆H₂₈ClNO₉

InChI: InChI=1/C26H27NO9.ClH/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31;/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3;1H/t10u,15?,16-,17?,21?,26-;/m0./s1

InChIKey: InChIKey=JVHPTYWUBOQMBP-RBOGCBTEBK
SMILES: CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl

Names:
    Daunomycin, 4-demethoxy-, hydrochloride
    EINECS 260-990-7
    Idamycin PFS
    Idamycin
    Idarubicin hydrochloride [USAN:INN]
    idarubicin hydrochloride
    IMI 30
    (1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside, hydrochloride
    (7S,9R)-9-acetyl-7-(4-amino-5-hydroxy-6-methyl-oxan-2-yl)oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride
    (7S-cis)-9-Acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacene-5,12-dione hydrochloride
    4-Demethoxydaunorubicin hydrochloride

Registries:
    PubChem CID 42593
    PubChem ID 183105